![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The road to HCV elimination: entering the final stretch or chasing a moving finish line?
|
|
|
EASL International Liver Congress, June 23-26, 2021
R. Fridriksdottir1, Sigurdur Olafsson 1,2 , Valgerdur Runarsdottir3, Ingunn Hansdottir3,4, Thorarinn Tyrfingsson3, Thorvardur J. Löve2,7, Ottar M. Bergmann1, Einar S. Björnsson1,2, Birgir Johannsson5, Bryndis Sigurdardottir5, Arthur Löve2, 6, Guorun Erna Baldvinsdóttir6, Ubaldo Benitez Hernandez7, Maria Heimisdottir2, 8, Magnus Gottfredsson2,5,7, and the TraP Hep C working group
1Department of Gastroenterology and Hepatology, Landspitali University Hospital , 2Faculty of Medicine, School of Health Sciences, University of Iceland, 3SAA National Center for Addiction Medicine -Reykjavik Iceland, 4Faculty of Psychology, School of Health Sciences, University of Iceland, 5Department of Infectious Diseases, Landspitali University Hospital, 6Department of Virology, 7Department of Science, Landspitali University Hospital , Reykjavik, Iceland, 8Icelandic Health Insurance, Reykavik, Iceland.
![0703211](../images/070321/070321-2/0703211.gif)
![0703212](../images/070321/070321-2/0703212.gif)
![0703213](../images/070321/070321-2/0703213.gif)
![0703214](../images/070321/070321-2/0703214.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|